Back to Search Start Over

Access and unmet needs to multiple sclerosis care in a cohort of Argentinean patients

Authors :
Ricardo Alonso
Edgar Carnero Contentti
Surai Mellinger
María Eugenia Balbuena
Orlando Garcea
Vladimiro Sinay
Sebastián Ianardi
Verónica Tkachuk
Leonel Migliacci
Mónica Perassolo
Adriana Carrá
Raúl Piedrabuena
Susana Liwacki
Fatima Pagani Cassara
Santiago Tizio
Emiliano Ruiz Romagnoli
Pablo A. López
Mathias Qüesta Laudani
Emanuel Silva
Carolina Mainella
Mariela Cabrera
Juan Pablo Pettinicchi
Javier Pablo Hryb
José Luis Di Pace
Christian Bortoluzzi
María Celeste Curbelo
Source :
Multiple sclerosis and related disorders. 33
Publication Year :
2018

Abstract

Background Multiple sclerosis (MS) has a low prevalence in Argentina. However, MS has a high burden of disease, which implies frequent neurological visits, magnetic resonance images (MRI) use and chronic MS medication during follow-up, with a high impact on the healthcare system. Therefore, MS care is essential to optimize disease management and improve patients’ outcome. We aimed to evaluate the access and barriers to MS care and identified differences in treatment and management of MS patients over a period of 12 months in an Argentinean cohort. Methods A cross-sectional study based on a self-administered survey was carried out from August to December 2017 in 13 provinces from Argentina. MS patients (n = 219) were divided into three groups as follows: prepaid health insurance (PHI), social health insurance (SHI) and state-run health insurance (SRHI, Public Health Ministry) and they were assessed in order to detect differences in employment, access and barriers to MS care (neurological visit, MRI use and MS medication). Results A total of 185 (84.5%) MS patients were employed (full-time: 59%), 34 (15.5%) were currently unemployed and 15 (6.8%) retired by MS. In addition, 132 had SHI, 45 PHI and 40 SRHI. No statistical differences were found in disease severity, frequency of neurological visit, waiting time for neurological visit as well as frequency and waiting time for MRI use. MS patients with SRHI experienced a longer waiting time (first prescription and during follow-up) and inappropriate delivery of MS medication during follow-up compared to MS patients with PHI and SHI. A total of 8/45 (17.7%) in PHI, 17/40 (42.5%) in SRHI and 25/132 (18.9%) in SHI did not receive the MS medication as properly as prescribed for their neurologists. PHI was independently associated with appropriate delivery of MS medication (OR = 0.81, p = 0.01). Conclusion This study showed that MS patients had access barriers to receive MS medication properly, especially those with SRHI (public sector).

Details

ISSN :
22110356
Volume :
33
Database :
OpenAIRE
Journal :
Multiple sclerosis and related disorders
Accession number :
edsair.doi.dedup.....773bcce5815a8ed14e755400bc48a417